These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 38275516)

  • 21. Do the Bugs in Your Gut Eat Your Memories? Relationship between Gut Microbiota and Alzheimer's Disease.
    Borsom EM; Lee K; Cope EK
    Brain Sci; 2020 Nov; 10(11):. PubMed ID: 33153085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation.
    Chen C; Liao J; Xia Y; Liu X; Jones R; Haran J; McCormick B; Sampson TR; Alam A; Ye K
    Gut; 2022 Nov; 71(11):2233-2252. PubMed ID: 35017199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of aryl hydrocarbon receptor (AhR) in Alzheimer's disease: role of tryptophan metabolites generated by gut host-microbiota.
    Salminen A
    J Mol Med (Berl); 2023 Mar; 101(3):201-222. PubMed ID: 36757399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    Kowalski K; Mulak A
    J Neurogastroenterol Motil; 2019 Jan; 25(1):48-60. PubMed ID: 30646475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
    Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
    J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagic dysfunction in Alzheimer's disease: Cellular and molecular mechanistic approaches to halt Alzheimer's pathogenesis.
    Uddin MS; Mamun AA; Labu ZK; Hidalgo-Lanussa O; Barreto GE; Ashraf GM
    J Cell Physiol; 2019 Jun; 234(6):8094-8112. PubMed ID: 30362531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Endocannabinoid System: A Bridge between Alzheimer's Disease and Gut Microbiota.
    Bisogno T; Lauritano A; Piscitelli F
    Life (Basel); 2021 Sep; 11(9):. PubMed ID: 34575083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Traditional Chinese medicine for the treatment of Alzheimer's disease: A focus on the microbiota-gut-brain axis.
    Ma L; Jiang X; Huang Q; Chen W; Zhang H; Pei H; Cao Y; Wang H; Li H
    Biomed Pharmacother; 2023 Sep; 165():115244. PubMed ID: 37516021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    Li Y; Wang R; Li Q; Wang YJ; Guo J
    J Alzheimers Dis; 2021; 83(3):963-976. PubMed ID: 34366348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition Mechanisms of (-)-Epigallocatechin-3-gallate and Genistein on Amyloid-beta 42 Peptide of Alzheimer's Disease via Molecular Simulations.
    Fang M; Zhang Q; Wang X; Su K; Guan P; Hu X
    ACS Omega; 2022 Jun; 7(23):19665-19675. PubMed ID: 35721940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut Microbiota Dysbiosis Induced by Decreasing Endogenous Melatonin Mediates the Pathogenesis of Alzheimer's Disease and Obesity.
    Zhang B; Chen T; Cao M; Yuan C; Reiter RJ; Zhao Z; Zhao Y; Chen L; Fan W; Wang X; Zhou X; Li C
    Front Immunol; 2022; 13():900132. PubMed ID: 35619714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Review on the Protective Effects of Probiotics against Alzheimer's Disease.
    Mishra V; Yadav D; Solanki KS; Koul B; Song M
    Biology (Basel); 2023 Dec; 13(1):. PubMed ID: 38248439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
    Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
    J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?
    Janeiro MH; Ramírez MJ; Solas M
    Cell Mol Neurobiol; 2022 Mar; 42(2):377-387. PubMed ID: 33400081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NLRP1 Inflammasome Activation in the Hippocampal Formation in Alzheimer's Disease: Correlation with Neuropathological Changes and Unbiasedly Estimated Neuronal Loss.
    Španić E; Langer Horvat L; Ilić K; Hof PR; Šimić G
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysbiosis and Alzheimer's Disease: A Role for Chronic Stress?
    Sharma VK; Singh TG; Garg N; Dhiman S; Gupta S; Rahman MH; Najda A; Walasek-Janusz M; Kamel M; Albadrani GM; Akhtar MF; Saleem A; Altyar AE; Abdel-Daim MM
    Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33946488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut-brain axis through the lens of gut microbiota and their relationships with Alzheimer's disease pathology: Review and recommendations.
    L K; Ng TKS; Wee HN; Ching J
    Mech Ageing Dev; 2023 Apr; 211():111787. PubMed ID: 36736919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease.
    Susmitha G; Kumar R
    Neuropharmacology; 2023 May; 229():109478. PubMed ID: 36871788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.